Note 9 - Quarterly Results for 2019 and 2018 (Unaudited)

12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Quarterly Financial Information [Text Block]

NOTE

9

– Quarterly Results for

2019

and

2018

(Unaudited):

(In thousands, except shares and per share data)

	Quarters Ended
	March 31, 2019		June 30, 2019		September 30, 2019		December 31, 2019
Net sales	$	86,552	$	92,270	$	89,466	$	108,413
Gross profit		30,268		32,343		31,451		34,867
Income before taxes on income		2,976		3,652		4,630		4,028
Net income		2,376		2,781		3,921		2,988
Net income per share:
Basic	$	0.16	$	0.19	$	0.26	$	0.20
Diluted	$	0.16	$	0.18	$	0.26	$	0.20
Average Outstanding Shares (Basic)		14,927,341		14,952,802		14,947,552		14,952,963
Average Outstanding Shares (Diluted)		15,262,654		15,287,357		15,266,850		15,248,770

	Quarters Ended
	March 31, 2018		June 30, 2018(1)		September 30, 2018		December 31, 2018
Net sales	$	73,087	$	82,392	$	95,870	$	95,001
Gross profit		24,875		29,278		33,800		33,744
Income before taxes on income		3,320		5,097		7,282		5,696
Net income		2,450		3,817		6,122		4,586
Net income per share:
Basic	$	0.17	$	0.26	$	0.41	$	0.31
Diluted	$	0.16	$	0.25	$	0.39	$	0.30
Average Outstanding Shares (Basic)		14,821,659		14,956,221		15,010,660		14,962,603
Average Outstanding Shares (Diluted)		15,457,629		15,559,404		15,499,894		15,371,606

( 1 )  On May 2, 2018, the Company acquired CID, which manufactures medical uniforms, lab coats, and layers, and sells its products to specialty uniform retailers, ecommerce medical uniform retailers, and other retailers. For further details relating to this acquisition, refer to Note 18 .